Ressourcenallokation in der Onkologie
作者： C. Gundermann , E. Eigendorff , M. Hartmann
DOI: 10.1007/S00761-015-2955-8
关键词:
摘要: Hintergrund Die Ressourcen im Gesundheitssystem sind begrenzt. Daher stellt sich die Frage, fur welche Zwecke vorhandenen in verschiedenen Landern eingesetzt werden.
springer.com
sci-hub.se 参考文章(9)
Michel P Coleman, Delia-Marina Alexe, T Albreht, Martin McKee, World Health Organization, None, Responding to the challenge of cancer in Europe. Institute of Public Health of the Republic of Slovenia. ,(2008)
B. Jönsson, F. Lichtenberg, N. Wilking, Reply to ‘Not credible: a subversion of science by the pharmaceutical industry. Commentary on A global comparison regarding patient access to cancer drugs (Annals of Oncology 2007, vol 18, Suppl 3, pp1-75)’ by Michel P Coleman Annals of Oncology. ,vol. 18, pp. 1585- 1587 ,(2007) , 10.1093/ANNONC/MDM397
Michael Hartmann, Roland Kath, Christin Gundermann, Oncological Resource Allocation in Germany Onkologie. ,vol. 31, pp. 85- 89 ,(2008) , 10.1159/000113465
Ramon Luengo-Fernandez, Jose Leal, Alastair Gray, Richard Sullivan, Economic burden of cancer across the European Union: a population-based cost analysis The Lancet Oncology. ,vol. 14, pp. 1165- 1174 ,(2013) , 10.1016/S1470-2045(13)70442-X
Davide Radice, Alberto Redaelli, Breast cancer management: quality-of-life and cost considerations. PharmacoEconomics. ,vol. 21, pp. 383- 396 ,(2003) , 10.2165/00019053-200321060-00003
M. J. Thun, J. O. DeLancey, M. M. Center, A. Jemal, E. M. Ward, The global burden of cancer: priorities for prevention. Carcinogenesis. ,vol. 31, pp. 100- 110 ,(2010) , 10.1093/CARCIN/BGP263
Chris S Payne, Expenditure on healthcare in the UK: 2012 ,(2014)
Ti, Gesundheitsberichterstattung des Bundes Krankenhaus-Hygiene + Infektionsverhütung. ,vol. 32, pp. 56- ,(2010) , 10.1016/J.KHINF.2010.03.002
Sandra Caspritz, Christa Stegmaier, Peter Kaatsch, Jutta Hansmann, Sabine Luttmann, Claudia Spix, Juliane Folkerts, Stefan Hentschel, Anke Ernst, Josef Cernaj, Kristine Kranzhöfer, Alexander Katalinic, Krebs in Deutschland 2009/2010 Robert Koch-Institut. ,(2013) , 10.25646/3169